The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival in metastatic castration-resistant prostate cancer (mCRPC): A retrospective electronic medical record analysis of men treated with sipuleucel-T in community urology over 14 years.
 
Michael Fabrizio
Employment - Johnson and Johnson
Honoraria - Astellas Pharma; Bayer; Profound Medical; Sumitomo Pharma Oncology
Consulting or Advisory Role - Dendreon; Johnson and Johnson; specialty networks; Teleflex Medical
Speakers' Bureau - Astellas Pharma; Bayer; Pfizer; Pfizer; Sumitomo Pharma Oncology
Travel, Accommodations, Expenses - Astellas Pharma; Johnson & Johnson/Janssen
Other Relationship - Sage Mountain Global/The Atlantic Clinic; Sage Mountain Global/The Atlantic Clinic
 
Paul Monk
Consulting or Advisory Role - Dendreon; Myovant Sciences; Pfizer/NCCN; Sanofi
Research Funding - Arvinas (Inst); Bayer (Inst); BioXCell (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); regeneron (Inst)
 
Paul Sieber
Honoraria - Bayer; Foundation Medicine; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Dendren; Janssen; Merck; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); CG Therapeutics (Inst); Dendreon (Inst); Jansn (Inst); Merck (Inst); ORIC Pharmaceuticals (Inst); Pfize (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc; Bayer Germany; Dendreon; Merck; Pfizer/NCCN
 
Jason Hafron
Honoraria - Astellas Pharma; Bayer; Dendreon; Janssen Biotech; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Dendreon; Immunis.AI; Janssen Biotech; Myriad Genetics; Pfizer; Sumitomo Pharma Oncology
Speakers' Bureau - Astellas Pharma; Bayer; Blue Earth Diagnostics; Dendreon; Janssen Biotech; Sumitomo Pharma Oncology; Tolmar; UroGen pharma
Research Funding - Bayer; Dendreon; Janssen Biotech; Merck; miR Scientific; Myriad Genetics; Sumitomo Pharma Oncology
Patents, Royalties, Other Intellectual Property - Lipella Pharmaceuticals
Travel, Accommodations, Expenses - Blue Earth Diagnostics; Dendreon
 
Lawrence Karsh
Stock and Other Ownership Interests - Swan Valley Medical (I)
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Roche; Ferring; Janssen; Merck; Pfizer
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bioxell Pharma (Inst); Bristol-Myers Squibb/Sanofi (Inst); Cleveland Diagnostics; Dendreon (Inst); Exact Sciences (Inst); Ferring (Inst); FKD Therapies (Inst); Janssen (Inst); KDx Diagnostics (Inst); Merck (Inst); Myovant Sciences (Inst); Pfizer (Inst); Tavanta Therapeutics (Inst); Vaxiion (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; dendreon; Janssen; Pfizer
 
Bryan Mehlhaff
Honoraria - Astellas Pharma; Bayer; Dendreon; Janssen; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Janssen; Pfizer
Research Funding - Dendreon (Inst)
 
Christopher Pieczonka
Employment - Associated Medical Professionals of New York
Leadership - Associated Medical Professionals of New York; US UROLOGY PARTNERS; US UROLOGY PARTNERS
Stock and Other Ownership Interests - US Urology Partners
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen; Merck; Myovant Sciences; Novartis; Pfizer/Astellas; Sun Pharma
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Merck; Novartis; Pfizer/Astellas; Sun Pharma; Sun Pharma; Tolmar
Speakers' Bureau - Astellas Pharma; Astra Zenerca; Bayer; Dendreon; Janssen Oncology; Merck; Myovant Sciences; Pfizer; Sun Pharma
Research Funding - Advantagene; Astellas Pharma; AstraZeneca; Bayer; Candel Therapeutics (Inst); Dendreon; InVitae; InVitae; Janssen Oncology; Merck; Pfizer
 
Benjamin Lowentritt
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; Bayer; Blue Earth Diagnostics; Dendreon; Janssen Oncology; Merck; Pfizer; Sumitomo Pharma Oncology; Tolmar
Speakers' Bureau - Astellas Pharma; AstraZeneca/MedImmune; Bayer; Blue Earth Diagnostics; Janssen Oncology; Lantheus Medical Imaging; Merck; Myovant Sciences; Pfizer
Research Funding - Blue Earth Diagnostics; Dendreon; Janssen Oncology; Myovant Sciences
 
Katie Grant
Employment - Cardinal Health
Research Funding - Cardinal Health
 
Margaret Warner-Lubin
Employment - Dendreon Pharmaceuticals, LLC
 
Lorraine O'Donnell
Employment - Cardinal Health
Research Funding - Cardinal Health
 
Arpit Kashyap
Employment - Cardinal Health; SpringWorks Therapeutics
Research Funding - Cardinal Health; SpringWorks Therapeutics
 
Basil Wilson
Employment - Cardinal Health
Research Funding - Cardinal Health
 
Matthew Harmon
Employment - Dendreon Pharmaceuticals, LLC
Stock and Other Ownership Interests - Sana Biotechnology
 
Nicholas Lazarou
Employment - Cardinal Health
Research Funding - Cardinal Health
 
Nadeem Sheikh
Employment - Dendreon Pharmaceuticals, LLC
 
Neal Shore
Employment - GenesisCare
Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Peerview; Pfizer; Photocure; PlatformQ Health; Promaxo; Propella Therapeutics; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow